Copyright
©The Author(s) 2021.
World J Gastrointest Oncol. Jun 15, 2021; 13(6): 472-494
Published online Jun 15, 2021. doi: 10.4251/wjgo.v13.i6.472
Published online Jun 15, 2021. doi: 10.4251/wjgo.v13.i6.472
Table 1 Tumor-node-metastasis staging of pancreatic adenocarcinoma [American Joint Committee on Cancer Tumor-Node-Metastasis Staging of Pancreatic Cancer (8th edition, 2017)]-T staging
| T | Primary tumor |
| TX | Primary tumor cannot be assessed |
| T0 | No evidence of primary tumor |
| Tis | Carcinoma in situ. This includes high-grade pancreatic intraepithelial neoplasia (PanIn-3), intraductal papillary mucinous neoplasm with high-grade dysplasia, intraductal tubulopapillary neoplasm with high-grade dysplasia, and mucinous cystic neoplasm with high-grade dysplasia |
| T1 | Tumor ≤ 2 cm in greatest dimension |
| T1a | Tumor ≤ 0.5 cm in greatest dimension |
| T1b | Tumor > 0.5 cm and < 1 cm in greatest dimension |
| T1c | Tumor 1–2 cm in greatest dimension |
| T2 | Tumor > 2 cm and ≤ 4 cm in greatest dimension |
| T3 | Tumor > 4 cm in greatest dimension |
| T4 | Tumor involves the celiac axis, superior mesenteric artery, and/or common hepatic artery, regardless of size |
- Citation: Zeeshan MS, Ramzan Z. Current controversies and advances in the management of pancreatic adenocarcinoma. World J Gastrointest Oncol 2021; 13(6): 472-494
- URL: https://www.wjgnet.com/1948-5204/full/v13/i6/472.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i6.472